Extract
Whole blood lactate, pyruvate, and oxygen concentrations were measured simultaneously In the umbilical vein, fetal femoral artery, maternal artery, and uterine vein in 14 chronically catheterized pregnant ewes and their fetuses. Lactate was found to be taken up in significant amounts across the placental circulation by the fetuses, whereas pyruvate was not.
The lactate concentration of fetal blood was higher than that of maternal blood; however, fetal lactate levels correlated with maternal arterial levels ( P 5 0.01). The mean lactate concentrations in all samples were: common umbilical vein, 2.105 mM; fetal femoral artery, 1.986 mM; and maternal artery, 0.823 mM. Where uterine venous lactate concentrations were measured, the lactate content of the uterine vein exceeded that of the maternal artery by a mean of 0.088 mmol/liter ( P < 0.005). The mean fetal gain in lactate across the placental circulation was 0.118 mmol/liter ( P < 0.005).
This is equivalent to a gain of 1.2 g carbon/kg/24 hr by the growing lamb fetus. The mean fraction of fetal oxygen consumption that could be accounted for by oxidation of lactate was 0.32.
The pyruvate concentration of fetal blood was higher than that of maternal blood; however, fetal pyruvate levels correlated with maternal arterial levels ( P < 0.05). The mean pyruvate concentrations in all samples were: common umbilical vein, 0.084 mM, fetal femoral artery, 0.094 mM; and maternal artery, 0.053 mM. Where uterine venous pyruvate concentrations were measured, they exceeded the maternal arterial concentrations by a mean of 0.005 mmol/liter ( P = 0.001). Pyruvate appeared to be lost by the fetus across the placental circulation by a mean of 0.010 mmol/liter. This loss of pyruvate correlated with the placental fetal to maternal pyruvate concentration gradient ( P < 0.05).
Correlations between maternal arterial and fetal lactate concentrations imply that fetal lactate levels are influenced by maternal levels. The increase in lactate concentration of both fetal and maternal blood during circulation through the placenta indicates placental production of lactate. The pyruvate concentrations observed, however, are consistent with either fetal to maternal flow of pyruvate or placental production.
Speculation
Lactate, after glucose and amino acids, is the third most important fetal substrate identified in the fetal lamb. Its role as a fetal fuel now needs to be evaluated in other animal species.
The pregnant sheep, surgically prepared with indwelling fetal and maternal catheters, is a useful animal model for studying fetal metabolism in an undisturbed physiologic state. With the use of this animal preparation glucose (7, 12) , fructose (17) , amino acids (8, 10) ketones (13) , glycerol, free fatty acids (I I, 19) and acetate (6) have been investigated as possible fetal fuels. Of these substances only glucose, amino acids, and acetate have been shown to cross the placenta in significant amounts for use in fetal metabolism. Analyses of the carbon content of the lamb fetus and its waste products indicate that at least 7.69 g carbon/kg/24 hr must be supplied to the fetus during the last one-third of gestation (2) . Glucose, amino acids and acetate can account for only 77% of this carbon and their metabolism can account for, at most, 80% of the fetal oxygen consumption (2, 6, 10, 12). Additional substrates must therefore be used by the fetus in large amounts.
Lactate and pyruvate are fundamental intermediates in carbohy-drate metabolism. By themselves they can serve as the sole energy the fetus across the umbilical circulation, whereas pyruvate, in source for early mammalian embryo development in v i m (9 Each day after surgery, the pregnant ewes were brought into the laboratory from their stalls in mobile cages for at least 2 hr. During this time they had access to food and water. All blood samplings for lactate and pyruvate were done in the midmorning on well oxygenated fetuses with normal femoral arterial pH and blood gases (pH > 730; paO, > 18, paCO, < 55). Thirty-four studies for lactate content and 24 studies for pyruvate content were done on 14 fetuses of 110-133 days of gestation and 1-22 days (mean of 7 days) after surgery. Aliquots of blood, 2.5 ml, were withdrawn simultaneously from all catheterized vessels into hepa- Table I . D a t a from studies for l a c t a t e l 0 , ratios1 Lactatelo, ratio in these cases is taken a s 0.000, since 0% of the fetal oxygen consumption is accounted for by lactate metabolism. SCalculated using the mean lactate and oxygen uptakes. rinized syringes. Measurements of whole blood lactate and pyruvate concentrations were begun immediately. During 22 studies in 13 fetal lambs, an additional 1 d l cof blood was drawn from the fetal vessels and analyzed for sxygen content. Using these measurements, the lactate/O, ratio, the fraction of fetal oxygen consumption that would be consumed ,in completely oxidizing lactate to CO, and water, was calculated. since 3 mol oxygen are needed to oxidize each mole of lactate, the lactate to 0, ratio was defined as: (3 x Alactate)/AO,. Where Alactate and A 0 , represent the umbilical venous-arterial differences of lactate and oxygen, respectively, in millimoles per liter.
ANALYTICAL METHODS
Whole blood lactate and pyruvate concentrations were measured enzymatically using lactic dehydrogenase (15) and standard commercial reagents (21) . Our mean pamentage of error in duplicate fetal blood samples was 3.2% and on maternal samples was 6.8%. Oxygen content was measured on the Lex-0,-Con (22) . The accuracy of this method has been documented (18) and was substantiated in our laboratory by periodic checks with Van Slyke 0, contents.
Statistical analysis of our data was performed using the paired t-test and the correlation coefficient, where appropriate.
RESULTS

LACTATE
The lactate concedtration in fetal venous and arterial blood was always higher than in maternal venous and arterial blood. Both fetal umbilical venous and femoral arterial lactate levels correlated significantly with the maternal arterial levels (Fig. I) . The mean lactate concentrations for the 34 measurements were: common umbilical vein (CUV), 2.105 * 0.215 SEM mM; fetal femoral artery (FA), 1.986 * 0.220 mM; and maternal artery (MA), 0.823 * 0.083 SEM mM. The mean CUV-FA lactate difference was 0.1 18 * 0.034 SEM mmol/liter (1.07 * 0.308 SEM mg/100 ml), a highly significant difference with P < 0.005.
In the 28 studies in which uterine venous lactate concentrations were measured, the mean maternal arterial and uterine venous (UtV) lactate values were 0.847 + 0.095 SEM mM and 0.936 + 0.093 mM, respectively. The uterine venous concentration was significantly higher by a mean of 0.088 + 0.026 SEM mmol/liter, with P < 0.005. The results from the 22 studies in which oxygen content was measured and lactate/O, ratios calculated are presented in Table 1 . Of the 22 CUV-FA sample pairs analyzed for oxygen content, 3 had a slightly higher lactate concentration in the FA than in the CUV. In these instances the lactate/O, ratio is considered to be zero, since 0% of the fetal oxygen consumption is accounted for by lactate metabolism. The mean lactate/O, ratio, calculated using the mean lactate and oxygen uptakes in these studies. is 0.324.
The pyruvate content of either fetal venous or arterial blood was higher than of either maternal venous or arterial blood. Fetal umbilical venous and femoral arterial pyruvate levels correlated with maternal arterial levels (Fig. 2) . Twenty-four measurements of pyruvate concentration were done on the CUV, FA, and MA. The mean pyruvate concentration for each vessel was: CUV, 0.084 + 0.008 SEM mM; FA 0.094 * 0.009 SEM mM; and MA, 0.053 * 0.003 SEM mM. In 15 out of the 24 CUV-FA sample pairs, the pyruvate concentration was higher in the fetal artery. The mean FA-CUV difference was 0.010 * 0.006 SEM mmol/liter, which is not statistically significant. However, a correlation was found between the pyruvate concentration gradient across the placenta (FA-MA) and fetal loss of pyruvate (FA-CUV difference) (Fig. 3) .
In 18 studies, the uterine venous pyruvate concentration was measured. In these samples the mean pyruvate concentration in the UtV was 0.057 0.003 mM and in the maternal artery was 0.052 0.004 SEM mM. The mean UtV-MA pyruvate difference was 0.005 * 0.001 SEM mmol/liter, a highly significant difference with P < 0.00 1.
In both fetal vessels studied, the pyruvate levels showed significant correlation with the lactate levels ( P < 0.01 in the common umbilical vein and P < 0.001 in the fetal femoral artery).
DISCUSSION
The 0.118 mmol/liter lactate being taken up by the fetal lamb across the placental circulation represents a large contribution to fetal metabolism. Assuming a mean umbilical blood flow of 200 cc/kg/min in the last third of gestation in the lamb (14), 33.98 mmol/kg/24 hr (3.08 g/kg/24 hr) lactate is being utilized. Lactate is therefore one of the major fetal substrates, only glucose and amino acids being quantitatively more important.
Of the 7.69 g carbon/kg/24 hr crossing the placenta to the lamb fetus during the last one-third of gestation, the amount of carbon per kg124 hr provided by fetal glucose uptake is between 1.8 and 2.6 grams (7, 12) and by acetate uptake is 0.56 g (6) . Calculations based on nitrogen balance studies in the fetal lamb, using an average C to N ratio in amino acids of 3.3 (2), indicate that 3.16 g carbon/kg/24 hr reach the fetus as amino acids. Lactate contains 0.036 g carbon/mmol and in the quantity being taken up would supply the lamb fetus with an additional 1.22 g carbon/kg/24 hr. With the identification of lactate as a fetal substrate we can now account for a total of 7.14 g carbon/kg/24 hr or 92% of fetal carbon supplies.
Assuming that all the glucose and acetate taken up by the fetus is oxidized, 80% of the fetal lamb's daily oxygen consumption can be accounted for by oxidation of these two substances (6, 12) and catabolism of amino acids (10) . The lactate/O, ratio indicates that approximately 32% of the oxygen consumption could also be used in complete oxidation of lactate. Assuming oxidation of the identified fetal substrates and using our figure of 32%, we are now in the position of accounting for mare than 100% of the fetal lamb's daily oxygen consumption. This is not surprising since all of the fetal substrates cannot be oxidized in toto. A proportion of them must be used in synthetic reactions in the growing fetus.
Lactate must be converted into pyruvate in order to be metabolized, and correlations between circulating levels of lactate and pyruvate are not unexpected. Lactate, once converted to pyruvate, can be used by the fetal lamb in gluconeogenesis (I) or oxidized in the Krebs cycle.
The concept that lactate can be taken up and utilized by the fetus is a new one. Past experiments were aimed at evaluating fetal or maternal lactate flow and indicated that the sheep placenta was impermeable to lactate (3, 4) . Movement of lactate from the fetus to the ewe was seen only at extremely high, abnormal fetal lactate levels (4). Recently Burd et al. (5) have reported their studies on fetal lactate metabolism in a chronic sheep preparation. They reached conclusions similar to ours, finding a significant umbilical venous-umbilical arterial lactate difference of 0.16 mmol/liter that could account for approximately 25% (range 0-79%) of their fetuses oxidative metabolism. With documentation that lactate is taken up by the fetus across the placental circulation, the previously seen low diffusibility of lactate back toward the ewe is not surprising.
The source of the lactate that is being transferred to the fetus is unclear. Correlations'between maternal arterial and fetal lactate concentrations imply that fetal levels are influenced by maternal levels. If maternal blood serves as a source of fetal lactate, active transport across the placenta against a concentration gradient is involved. However, maternal uterine blood does not lose, but gains lactate, an observation substantiated by others (5) . Most likely, the sheep placenta, which is known to produce lactate from other substrates (16) , is depositing it into both the fetal and maternal circulations.
Pyruvate, in contrast to lactate, is not taken up by the fetus and makes no measurable contribution as a fetal substrate. The significantly higher pyruvate levels in the uterine vein than in the maternal artery and the trend toward higher values in the fetal artery than in the umbilical vein are consistent with a net movement of pyruvate from fetus to mother. A similar observation was made in experiments on the acutely hypoxic exteriorized fetus (4) . Alternatively, the placenta could be producing pyruvate and supplying it to the maternal circulation.
S U M M A R Y
Lactate and pyruvate concentration differences across the fetal umbilical circulation and the maternal uterine circulation were measured in a chronic sheep preparation. Significant gains in lactate in both the fetal and maternal circulations were observed. The lactate taken up by the fetus would account for 32% of fetal oxygen consumption if oxidized. There was no significant change in pyruvate concentration across the fetal umbilical circulation; however, pyruvate was gained by maternal uterine blood.
